Multimedia

View table

Table1

Restricted access
Subject Index
View table

Table1

Restricted access
CRT-100.42 Safety And Efficacy Of A Novel Sirolimus-eluting Coronary Stent With Unique Coating Technology In Patients With Diabetes
Figure1

Restricted access
Mortality Following Nonemergent, Uncomplicated Target Lesion Revascularization After Percutaneous Coronary Intervention
Figure 1

Restricted access
Mortality Following Nonemergent, Uncomplicated Target Lesion Revascularization After Percutaneous Coronary Intervention
View table

Table 1

Restricted access
Mortality Following Nonemergent, Uncomplicated Target Lesion Revascularization After Percutaneous Coronary Intervention
Figure 2

Restricted access
Mortality Following Nonemergent, Uncomplicated Target Lesion Revascularization After Percutaneous Coronary Intervention
View table

Table 2

Restricted access
Mortality Following Nonemergent, Uncomplicated Target Lesion Revascularization After Percutaneous Coronary Intervention
View table

Table 3

Restricted access
Mortality Following Nonemergent, Uncomplicated Target Lesion Revascularization After Percutaneous Coronary Intervention
Figure 3

Restricted access
Mortality Following Nonemergent, Uncomplicated Target Lesion Revascularization After Percutaneous Coronary Intervention
Figure 4

Restricted access
Mortality Following Nonemergent, Uncomplicated Target Lesion Revascularization After Percutaneous Coronary Intervention
Figure 5

Restricted access
Mortality Following Nonemergent, Uncomplicated Target Lesion Revascularization After Percutaneous Coronary Intervention
View table

Table 4

Restricted access
Mortality Following Nonemergent, Uncomplicated Target Lesion Revascularization After Percutaneous Coronary Intervention
View table

Table 1

Restricted access
Hybrid Coronary Revascularization in Selected Patients With Multivessel Disease
Figure 1

Restricted access
Hybrid Coronary Revascularization in Selected Patients With Multivessel Disease
View table

Table 2

Restricted access
Hybrid Coronary Revascularization in Selected Patients With Multivessel Disease
View table

Table 3

Restricted access
Hybrid Coronary Revascularization in Selected Patients With Multivessel Disease
Figure 1

Restricted access
In Vivo Stent Frame Infolding of a Self-Expanding Transcatheter Aortic Valve After Resheathing
Figure2

Restricted access
In Vivo Stent Frame Infolding of a Self-Expanding Transcatheter Aortic Valve After Resheathing
Figure3

Restricted access
In Vivo Stent Frame Infolding of a Self-Expanding Transcatheter Aortic Valve After Resheathing
Figure 1

Restricted access
Histopathology of Coronary Fibromuscular Dysplasia Causing Spontaneous Coronary Artery Dissection

Pages

Advertisement